| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $15.6M | +22.2% |
| SG&A Expense | $7.0M | +9.5% |
| Operating Income | -$22.5M | -17.9% |
| Net Income | -$21.8M | -11.2% |
| EPS (Basic) | -$5.51 | +61.0% |
| EPS (Diluted) | -$5.51 | +61.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.9M | +1953.5% |
| Accounts Receivable | $229K | +316.4% |
| Current Assets | $51.7M | +1285.7% |
| Total Assets | $52.2M | +1069.6% |
| Current Liabilities | $4.9M | +23.8% |
| Total Liabilities | $5.0M | +16.4% |
| Stockholders' Equity | $47.2M | — |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.4M | -7.7% |
| Capital Expenditures | $179K | — |
| Investing Cash Flow | -$179K | — |
| Financing Cash Flow | $68.0M | +324.8% |
| Free Cash Flow | -$19.6M | -8.7% |